Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems

Table 6

Clinical analysis of hepatic failure treated by nonbioartificial liver treatment.

Index	Mean (before and after)	Standard deviation (front and back)	The value of P
ALT(U/L)	117.06, 69.60	236.50, 76.28	0.051
AST(U/L)	185.15, 141.23	250.61, 138.12	0.003
ALB(g/L)	30.59, 28.33	4.61, 2.81	0.001
ALP(U/L)	95.54, 86.33	33.33, 31.24	0.01
r-GT(U/L)	60.77, 49.06	36.66, 21.87	0.003
TBil(umol/L)	372.53, 263.53	229.01, 170.05	0.001
PT(s)	24.66, 19.74	8.36, 5.82	0.001

Note.Compared with the preclinical indexes in the nonbioartificial liver treatment P < 0.01. Compared with the preclinical indexes in the nonbioartificial liver treatment P 0.001. There was significant statistical significance.